Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Insider Weekends: First Insider Purchase At Starbucks In Nearly 4 Years
06:55am, Tuesday, 17'th May 2022 Seeking Alpha
Insiders once again stepped up their purchases to take advantage of prices. Uber’s CEO bought 200,000 shares and Mr. Schultz picked up $10 million worth of Starbucks.
Why Dynavax Stock Won on a Losing Monday for the Market
10:46pm, Monday, 16'th May 2022 The Motley Fool
The company earns an Emergency Use Authorization from a well-off Middle Eastern country.
Top Analyst Reports for NVIDIA, Home Depot, Pfizer & Others
06:53pm, Monday, 16'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Home Depot, Inc. (HD), and Pfizer Inc. (PFE).
12 stocks to consider for the next leg of the bull market
07:45pm, Saturday, 14'th May 2022 MarketWatch
These companies are typically uncorrelated to indexes, giving investors a chance to outperform.
3 Supercharged Dividend Stocks to Buy in the Stock Market Sell-Off
02:30pm, Saturday, 14'th May 2022 The Motley Fool
Dividend stocks are a safe haven for investors in a period of market turmoil.
3 Dirt-Cheap Stocks You Can Buy Right Now
11:04am, Saturday, 14'th May 2022 The Motley Fool
These stocks are inexpensive yet have solid underlying businesses.
3 Reasons That Novavax Investors Could Be Looking For The Door
03:00pm, Friday, 13'th May 2022 The Motley Fool
Not enough is going right, and there's plenty going awry.
Some patients and physicians say it's hard to find Paxlovid, Pfizer's COVID-19 pill
02:41pm, Friday, 13'th May 2022 MarketWatch
The pill has become an increasingly important tool in the nation’s defense against COVID-19 as mask mandates have lifted and people have returned to their non-distanced lives.
This Is the Most Important Number From Novavax's Q1 Earnings
02:00pm, Friday, 13'th May 2022 The Motley Fool
Novavax is doing well now, but what about the future?
Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update
12:10pm, Friday, 13'th May 2022 Zacks Investment Research
Pfizer (PFE) is set to buy migraine drugmaker, Biohaven Pharmaceuticals for $11.6 billion. Bayer (BAYRY) beats Q1 earnings and sales expectations.
Is This Vaccine Stock in Trouble -- or Ready for a Rebound?
10:00am, Friday, 13'th May 2022 The Motley Fool
Inovio may be at a turning point.
Here's Why June Could Make Or Break These 3 Vaccine Stocks
02:15pm, Thursday, 12'th May 2022 The Motley Fool
A slew of regulatory catalysts could bring delight -- or disaster.
Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID
12:02pm, Thursday, 12'th May 2022 Zacks Investment Research
The FDA grants full approval to Lilly (LLY) and Incyte for COVID-19 in certain hospitalized adults. Olumiant is already authorized for emergency use for this indication since November 2020.
Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider
06:12pm, Wednesday, 11'th May 2022 Zacks Investment Research
Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. The transaction is likely to be completed by early 2023. BHVN also reports wider-than-expected Q1 loss.
Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss Estimates
06:08pm, Wednesday, 11'th May 2022 Zacks Investment Research
Exelixis (EXEL) beats on earnings but misses on revenues in the first quarter. While the top line increases on a year-over-year basis, the bottom line improves from the year-ago breakeven figure.
